{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:10:18Z","timestamp":1791277818540,"version":"4.1.0"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2890","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T02:09:07Z","timestamp":1414807747000},"page":"2523-2527","source":"Crossref","is-referenced-by-count":16,"title":["Acute Thrombocytopenia after Initiating Anticoagulation with Rivaroxaban"],"prefix":"10.2169","volume":"53","author":[{"given":"Yohei","family":"Mima","sequence":"first","affiliation":[{"name":"Department of Cerebrovascular Medicine, Neurology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Sangatsuda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, Neurology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Wakugawa","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, Neurology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, Neurology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361: 1139-1151, 2009.","DOI":"10.1056\/NEJMoa0905561"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365: 981-992, 2011.","DOI":"10.1056\/NEJMoa1107039"},{"key":"3","unstructured":"3. Hori M, Matsumoto M, Tanahashi N, et al. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation: the J-ROCKET AF study. Circ J 76: 2104-2111, 2012."},{"key":"4","unstructured":"4. Interview Form \"Xarelto\" 5th ed. Bayer HealthCare, Osaka, 2013: 30-31 (in Japanese)."},{"key":"5","unstructured":"5. Ruff CT, Giugliano RP, Antman EM, et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 160: 635-641, 2010."},{"key":"6","unstructured":"6. Attached document of rivaroxaban in Japan. 2nd ed. Bayer HealthCare, Osaka, 2012: 3-4 (in Japanese)."},{"key":"7","unstructured":"7. Attached document of lansoprazole in Japan. 18th ed. Takeda Pharmaceutical Company Limited, Osaka, 2013: 3 (in Japanese)."},{"key":"8","unstructured":"8. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7: 911-918, 2009."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kenney B, Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med 133: 309-314, 2009.","DOI":"10.5858\/133.2.309"},{"key":"10","unstructured":"10. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 129: 886-890, 1998."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/21\/53_53.2890\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T01:17:40Z","timestamp":1650503860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/21\/53_53.2890\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":10,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2890","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}